Key Takeaways from the SEC’s 2025 Exam Priorities

The Securities and Exchange Commission (SEC) has unveiled its examination priorities for 2025, focusing on key areas such as investment advisers, broker-dealers, cybersecurity, and crypto assets. This announcement, detailed by Eric Mikkelson and Carissa Occhipinto from Stinson LLP, provides a roadmap for registered investment advisers, investment companies, and broker-dealers to prepare for potential examinations.

Investment Advisers

The SEC’s Division of Examinations continues to emphasize the importance of fiduciary duties. Investment advisers must adhere to fiduciary standards, ensuring they act in the best interests of their clients. The Division will scrutinize compliance programs, particularly for advisers integrating artificial intelligence into their operations.

Broker-Dealers

Broker-dealers are under the spotlight with the continued enforcement of Regulation Best Interest. The Division will assess whether broker-dealers make recommendations that are in the best interests of their clients, with a keen eye on complex and high-risk products. Compliance with Form CRS, which provides crucial information about broker-dealers to retail investors, remains a top priority.

Cybersecurity and Crypto Assets

Cybersecurity measures are critical as the Division seeks to prevent service interruptions and protect investor information. The evolving landscape of crypto assets also demands attention, with examinations focusing on whether registrants adhere to standards of conduct and maintain robust compliance practices.

Emerging Risks

The Division highlights potential risks in financial technologies, particularly the use of AI and digital engagement practices. Firms must ensure their representations about AI capabilities are accurate and that they have adequate controls in place.
For more detailed insights, you can view the full original article on Stinson LLP’s website.
As the SEC navigates these priorities amidst a changing presidential administration, registrants are advised to conduct thorough reviews and consult with counsel to ensure compliance and readiness for the year ahead.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Donald Trump’s Historic Re-Election as U.S. President

In a stunning political comeback, Donald Trump has been re-elected as President of the United States, marking a significant moment in American history. This victory followed a fiercely contested race against Kamala Harris.

By |November 6, 2024|Categories: Article, Politics, U.S. Election|Tags: |0 Comments

AI Transformation in Healthcare: A Market on the Brink of Explosive Growth

The AI in Healthcare market, valued at USD 22.5 billion in 2023, is projected to skyrocket to USD 370.14 billion by 2032. This growth is fueled by a remarkable compound annual growth rate (CAGR) of 36.5%.

Propy Revolutionizes Home Inspections with Inspectify Partnership

Propy, a San Francisco-based real estate technology platform, has announced its strategic partnership with Inspectify, a leading property inspection platform. This collaboration... enables users to handle property inspections without leaving the Propy app, marking a new era of efficiency in real estate transactions.

AI’s Transformative Impact on the Insurance Sector Unveiled at Hong Kong FinTech Week 2024

"AI has evolved from a competitive advantage to an essential survival tool." Its ability to streamline claims handling, enhance transparency, and combat fraud is revolutionizing insurance operations.

By |November 5, 2024|Categories: Article, Finance, Technology|Tags: , |0 Comments

The Dawn of Artificial Intelligence in Healthcare

The revolution of artificial intelligence (AI) in healthcare has just begun, with vast potential to transform patient care, research, and drug discovery.